[Ile5,Trp23]PTHrP-(4-36) (human)



[Ile5,Trp23]PTHrP-(4-36) (human)

E1EE1I2II2Q3QQ3L4LL4L5LL5H6HH6D7DD7K8KK8G9GG9K10KK10S11SS11I12II12Q13QQ13D14DD14L15LL15R16RR16R17RR17R18RR18F19FF19W20WW20L21LL21H22HH22H23HH23L24LL24I25II25A26AA26E27EE27I28II28H29HH29T30TT30A31AA31E32EE32I33II33

SMILES None
InChIKey None
Sequence EIQLLHDKGKSIQDLRRRFWLHHLIAEIHTAEI

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

[Ile5,Trp23]PTHrP-(4-36) (human)

E1EE1I2II2Q3QQ3L4LL4L5LL5H6HH6D7DD7K8KK8G9GG9K10KK10S11SS11I12II12Q13QQ13D14DD14L15LL15R16RR16R17RR17R18RR18F19FF19W20WW20L21LL21H22HH22H23HH23L24LL24I25II25A26AA26E27EE27I28II28H29HH29T30TT30A31AA31E32EE32I33II33

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.